Barclays’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5K | Sell |
6,618
-109,668
| -94% | -$82.9K | ﹤0.01% | 4217 |
|
|
2025
Q1 | $76K | Sell |
116,286
-42,528
| -27% | -$27.8K | ﹤0.01% | 3770 |
|
|
2024
Q4 | $293K | Sell |
158,814
-114,205
| -42% | -$211K | ﹤0.01% | 3342 |
|
|
2024
Q3 | $944K | Buy |
273,019
+216,757
| +385% | +$749K | ﹤0.01% | 2649 |
|
|
2024
Q2 | $164K | Sell |
56,262
-23,476
| -29% | -$68.4K | ﹤0.01% | 3148 |
|
|
2024
Q1 | $450K | Sell |
79,738
-52,321
| -40% | -$295K | ﹤0.01% | 2898 |
|
|
2023
Q4 | $566K | Buy |
132,059
+69,480
| +111% | +$298K | ﹤0.01% | 2934 |
|
|
2023
Q3 | $217K | Buy |
62,579
+18,093
| +41% | +$62.7K | ﹤0.01% | 2991 |
|
|
2023
Q2 | $207K | Sell |
44,486
-76,658
| -63% | -$357K | ﹤0.01% | 3063 |
|
|
2023
Q1 | $559K | Buy |
121,144
+39,245
| +48% | +$181K | ﹤0.01% | 2561 |
|
|
2022
Q4 | $661K | Buy |
81,899
+61,470
| +301% | +$496K | ﹤0.01% | 2414 |
|
|
2022
Q3 | $114K | Sell |
20,429
-3,409
| -14% | -$19K | ﹤0.01% | 3367 |
|
|
2022
Q2 | $125K | Sell |
23,838
-29,753
| -56% | -$156K | ﹤0.01% | 3375 |
|
|
2022
Q1 | $441K | Sell |
53,591
-300,796
| -85% | -$2.48M | ﹤0.01% | 2886 |
|
|
2021
Q4 | $5.27M | Buy |
354,387
+23,763
| +7% | +$354K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $6.25M | Buy |
330,624
+91,630
| +38% | +$1.73M | ﹤0.01% | 1127 |
|
|
2021
Q2 | $4.44M | Sell |
238,994
-21,129
| -8% | -$393K | ﹤0.01% | 1268 |
|
|
2021
Q1 | $5.92M | Buy |
260,123
+30,004
| +13% | +$683K | ﹤0.01% | 1076 |
|
|
2020
Q4 | $5M | Sell |
230,119
-9,006
| -4% | -$195K | ﹤0.01% | 1027 |
|
|
2020
Q3 | $2.4M | Buy |
239,125
+1,766
| +0.7% | +$17.7K | ﹤0.01% | 1382 |
|
|
2020
Q2 | $1.84M | Buy |
237,359
+7,418
| +3% | +$57.5K | ﹤0.01% | 1531 |
|
|
2020
Q1 | $2.35M | Buy |
229,941
+211,642
| +1,157% | +$2.16M | ﹤0.01% | 1263 |
|
|
2019
Q4 | $202K | Buy |
18,299
+5,567
| +44% | +$61.5K | ﹤0.01% | 3168 |
|
|
2019
Q3 | $116K | Buy |
12,732
+3,006
| +31% | +$27.4K | ﹤0.01% | 3323 |
|
|
2019
Q2 | $111K | Buy |
9,726
+7,920
| +439% | +$90.4K | ﹤0.01% | 3529 |
|
|
2019
Q1 | $21K | Buy |
1,806
+807
| +81% | +$9.38K | ﹤0.01% | 3907 |
|
|
2018
Q4 | $9K | Buy |
+999
| New | +$9K | ﹤0.01% | 3582 |
|